Molecular action of the estrogen receptor and hormone dependency in breast cancer

Breast Cancer

Volumn 10, Issue 2, 2003, Pages 89-96

  Iwase, Hirotaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Coactivator; Corepressor; Estrogen receptor u 3

Indexed keywords

EID: 0242335773     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967632     Document Type: Review

References (65)

1. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WL: Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 37:106-110, 1977. (Pubitemid 8009283)
2. Bezwoda W, Esser J, Dansey R, Kessel I, Lange M: The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen. Cancer 68:867-872, 1991.
3. Evans R: The steroid and thyroid hormone receptor superfamily. Science 240:889-895, 1988.
4. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24:77-83, 1986. (Pubitemid 16047760)
5. Kato S: Estrogen receptor-mediated cross-talk with growth factor signaling pathways. Breast Cancer 8:3-9, 2001.
6. Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930, 1996. (Pubitemid 26190778)
7. Tremblay G, Tremblay A, Copeland N, Gilbert D J, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β. Mol Endocrinol 11:353-365, 1997. (Pubitemid 27106331)
8. Mosselman S, Polman J, Dijkema R: ER-beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53, 1996. (Pubitemid 26268330)
9. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA: Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82:4258-4265, 1997. (Pubitemid 27525550)
10. Menasce L, White G, Harrison C, Boyle, JM: Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17:263-265, 1993. (Pubitemid 23205095)
11. Ponglikitmongkol M, Green S, Chambon P: Genomic organization of the human oestrogen receptor gene. EMBOJ 7:3385-3388, 1988.
12. Iwase H, Kobayashi S: Alterations and Polymorphisms of the Estrogen Receptor Gene in Breast Cancer. Breast Cancer 4:57-66, 1997.
13. Chu S, Fuller P: Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol 132:195-199, 1997. (Pubitemid 27420314)
14. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M: Protein Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26:3505-3512, 1998. (Pubitemid 28347221)
15. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58:3197-3201, 1998. (Pubitemid 28371051)
16. Petersen D, Tkalcevic G, Koza-Taylor P, Turi TG, Brown TA: Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology 139:1082-1092, 1998. (Pubitemid 28510126)
17. Zhang Q, Hilsenbeck S, Fuqua S, Borg A: Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Bio159:251-260, 1996. (Pubitemid 27037931)
18. Murphy L, Dotzlaw H, Leygue E, Douglas D, Courts A, Watson PH: Estrogen receptor variants and mutations. J Steroid Biochem Mol Bio162:363-372, 1997. (Pubitemid 28012863)
19. Omoto Y, Iwase H, Iwata H, Hara Y, Toyama T, Ando Y, Kobayashi S: Expression of estrogen receptor alpha exon 5 and 7 deletion variant in human breast cancers. Breast Cancer 7:27-31, 2000.
20. Leclercq G: Molecular forms of the estrogen receptor in breast cancer. J Steroid Biochem Mol Biol 80:259-272, 2002. (Pubitemid 34304150)
21. Lonard D, Nawaz Z, Smith C, O'Malley BW: The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell Biol 5:939-948, 2000.
22. McKenna N, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW: Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Bio169:3-12, 1999. (Pubitemid 29305520)
23. Klinge CM: Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919, 2001. (Pubitemid 32685217)
24. Kushner P, Agard D, Greene G, Scanlan, TS, Shiau, AK, Uht, RM, Webb, P: Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Bio174:311-317, 2000. (Pubitemid 32126243)
25. Ogawa S, Inoue S, Watanabe T, Hiroi, H, Orimo A, Hosoi T, Ouchi Y, Muramatsu M: The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophys Res Commun 243:122-126, 1998. (Pubitemid 28414201)
26. Cowley S, Hoare S, Mosselman S, Parker MG: Estrogen receptors alpha and beta form heterodimers on DNA.J Biol Chem 272:19858-19862, 1997. (Pubitemid 27340081)
27. Pettersson K, Grandien K, Kuiper G, Gustafsson J A: Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol 11:1486-1496, 1997. (Pubitemid 27366759)
28. Paech K, Webb P, Kuiper G, Nilsson S Gustafsson, JA, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508-1510, 1997. (Pubitemid 27449239)
29. Dotzlaw H, Leygue E, Watson PH, Murphy LC: Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 82:2371-2374, 1997. (Pubitemid 27287615)
30. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R: Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 58:210-214, 1998. (Pubitemid 28047055)
31. Speirs V, Parkes AT, Kerin MJ, Walton DS, Carleton PJ, Fox JN, Atkin SL: Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 59:525-528, 1999. (Pubitemid 29076043)
32. Iwao K, Miyoshi Y, Egawa C, Ikeda N, Noguchi S: Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers. IntJ Cancer 88:733-736, 2000.
33. Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S, Iwase H: Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 163:207-212, 2001. (Pubitemid 32126367)
34. Pavao M, Traish AM: Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids 66:1-16, 2001.
35. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H: Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541, 2001. (Pubitemid 32685835)
36. Skliris GP, Carder PJ, Lansdown MR, Speirs V: Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? BrJ Cancer 84:1095-1098, 2001. (Pubitemid 32448508)
37. Saunders PT, Millar MR, Williams K, Macpherson S, Bayne C, O'Sullivan C, Anderson TJ, Groome NP, Miller WR: Expression of oestrogen receptor beta (ERbetal) protein in human breast cancer biopsies. Br J Cancer 86:250-256, 2002. (Pubitemid 34185154)
38. Gustafsson JA, Warner M: Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J Steroid Biochem Mol Biol 74:245-248, 2000. (Pubitemid 32140403)
39. Knowlden J, Gee J, Robertson J, Ellis IO, Nicholson RI: A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer. Int J Cancer 89:209-212, 2000. (Pubitemid 30185932)
40. Speirs V, Kerin M: Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 87:405-409, 2000. (Pubitemid 30192946)
41. Hu YF, Lau KM, Ho SM, Russo J: Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol 12:1225-1228, 1998. (Pubitemid 28239928)
42. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J, Lupu R: Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol Rep 7:157-167, 2000.
43. Jarvinen TA, Pelto-Huikko M, Holli K, Isola J: Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156:29-35, 2000. (Pubitemid 30644435)
44. Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M: Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32:113-118, 2001. (Pubitemid 32150637)
45. Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Gustafsson JA, Iwase H: Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. EurJ Cancer 38:380-386, 2002. (Pubitemid 34123315)
46. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Wilson TM, Moore JT: Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res 59:5425-5428, 1999. (Pubitemid 29526449)
47. Iwase H, Omoto Y, Toyama T, Hara Y, Iwata H, Kobayashi S: Clinical Significance of Estrogen Receptor beta in Breast Cancer. Breast Cancer 6:325-330, 1999.
48. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M, Gustafsson JA: Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9:1-13, 2002. (Pubitemid 34302928)
49. Horwitz K, Jackson T, Bain D, Richer JI~ Takimoto GS, Tung L: Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177, 1996. (Pubitemid 26330950)
50. Greenblatt J: Roles of TFID in transcriptional initiation by RNA polymerase I. Cell 66:1067-1070, 1991. (Pubitemid 121001396)
51. Buratowski S: The basics of basal transcription by RNA polymerase I. Cell 77:1-3, 1994. (Pubitemid 24184679)
52. Lee S, Hahn S: Model for binding of transcription factor TFIIB to the TBP-DNA complex. Nature 376:609-612, 1995.
53. Guan X, Xu J, Anzick S, Zhang H, Trent JM, Meltzer PS: Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res 56:3446-3450, 1996. (Pubitemid 26251635)
54. Loe C, Chen J: The SRC family of nuclear receptor coactivators. Gene 245:1-11, 2002.
55. Smith C, Onate SA, Tsai MJ, O'Malley BW: CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptordependent transcription. Proc Natl Acad Sci USA 93:8884-8888, 1996. (Pubitemid 26281986)
56. Onate S, Tsai S, Tsai M, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357, 1995.
57. Voegel J, Heine M, Zechel C, Chambon P, Gronemeyer H: TIF2, a 160 κDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675, 1996. (Pubitemid 26239779)
58. Takeshita A, Yen P, Misiti S, Cardona GR, Liu Y, Chin WW: Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology 137:3594-3597, 1996. (Pubitemid 26250217)
59. Anzick S, Kononen J, Walker R, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM, Meltzer PS: AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277:965-968, 1997. (Pubitemid 27366683)
60. Bouras T, Southey M, Venter D: Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 61:903-907, 2001. (Pubitemid 32174400)
61. Hara Y, Yamashita H, Toyama T, Sugiura H, Kobayashi S, Iwase H: Clinical significance of AIB1 expression in human breast cancers. Proceeding, The lOth Anual meeting of the Japanese Breast Cancer Scociety 10:155, 2002.
62. Jackson T, Richer J, Bain D, Takimoto GS, Tung L, Horwitz K: The partial agonist activity of antagonistoccupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol Endocrinol 11:693-705, 1997. (Pubitemid 27225297)
63. Graham J, Bain D, Richer J, Jackson TA, Tung L, Horwitz KB: Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer. Steroids 65:579-584, 2000.
64. Burger H: Selective oestrogen receptor modulators. Horm Res 53:25-29, 2000.
65. Smith C, Nawaz Z, BW OM: Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol 11:665-666, 1997.